For the tumor region and IM together, higher CD4+ (DFS, P=0.0156; OS, P=0.0121) and CD19+ (DFS, P=0.0206; OS, P=0.0309) signals were significantly correlated with better survival. The gene discussed is CD19; the disease is neoplasm.